Cost-utility and budget impact analysis for stopping the inappropriate use of proton pump inhibitors after cessation of NSAID or low-dose acetylsalicylic acid treatment
In accordance with current guidelines, proton pump inhibitors (PPIs) are now generally prescribed as a protective co-medication in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose acetylsalicylic acid (LDASA). However, less attention is paid to the corresponding discontinua...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2020
|
| In: |
Drugs & aging
Year: 2019, Jahrgang: 37, Heft: 1, Pages: 67-74 |
| ISSN: | 1179-1969 |
| DOI: | 10.1007/s40266-019-00713-5 |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1007/s40266-019-00713-5 |
| Verfasserangaben: | Sek Hung Chau, Reinier Luuk Sluiter, Jacqueline Geertruida Hugtenburg, Michel Wensing, Wietske Kievit, Martina Teichert |
| Zusammenfassung: | In accordance with current guidelines, proton pump inhibitors (PPIs) are now generally prescribed as a protective co-medication in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose acetylsalicylic acid (LDASA). However, less attention is paid to the corresponding discontinuation of a PPI after cessation of NSAID or LDASA treatment. |
|---|---|
| Beschreibung: | Published online: 27 September 2019 Gesehen am 01.04.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1179-1969 |
| DOI: | 10.1007/s40266-019-00713-5 |